Contact information
Research groups
Xinchun Gu
PhD
Researcher
I am an epidemiologist and pharmacist, with my research primarily focusing on the surveillance of infectious diseases in England and the evaluation of vaccine uptake, efficacy and safety. I currently use primary care data from the Oxford-Royal College of General Practitioners Research and Surveillance Centre (Oxford-RCGP RSC), which collects data from more than 1900 practices across England and Wales, to evaluate the trend of respiratory infectious disease in the UK. I am also experienced in using primary care data from Clinical Practice Research Datalink (CPRD) and its linked external databases.
I currently supervise postgraduate students in the MSc in Applied Digital Health. I am a tutor for the Meta-Analysis module and the Big Data Epidemiology module in MSc degree programs.
Prior to joining the University of Oxford, I completed my PhD in pharmacoepidemiology at the University of Manchester, focusing on the safety of gabapentinoids in patients with chronic non-cancer pain in primary care. I earned a Master's degree in Clinical Pharmacy from Peking University, specialising in endocrinology, and a Bachelor's degree in Pharmaceutical Science from Sun Yat-Sen University.
Recent publications
-
Clinical Characteristics of Virologically Confirmed Respiratory Syncytial Virus in English Primary Care: Protocol for an Observational Study of Acute Respiratory Infection
Journal article
Hoang U. et al, (2025), JMIR Research Protocols, 14
-
COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales
Journal article
Gu X. et al, (2024), npj Vaccines, 9
-
A protocol to differentiate the COVID-19 infection and vaccine experiences of patients with systemic, single site and overlap immune-mediated inflammatory disease (IMID) (Preprint)
Preprint
Leston M. et al, (2024)
-
Sleeper frameworks for Pathogen X: surveillance, risk stratification, and the effectiveness and safety of therapeutic interventions
Journal article
de Lusignan S. et al, (2024), The Lancet Infectious Diseases, 24, e417 - e418
-
A Public Health Response to Pathogen X: Safeguarding Communities through Frameworks for Emerging Epidemics and Pandemics
Report
Shi T. et al, (2024)